Stock market week-in-review for 5 large GI companies — July 31-Aug. 4

Written by Eric Oliver | August 08, 2017 | Print  |

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of July 31 to Aug. 4.

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $253.07 on July 31
Peaked: $255.22 on July 31
Closed: $242.55 on Aug. 4
Percent change between July 31 and Aug. 4: -4.15 percent

2. Exact Sciences Corp.

Opened: $39.47 on July 31
Peaked: $39.59 on July 31
Closed: $38.69 on Aug. 4
Percent change between July 31 and Aug. 4: -1.97 percent

3. Johnson & Johnson

Opened: $131.84 on July 31
Peaked: $133.91 on Aug. 4
Closed: $133.11 on Aug. 4
Percent change between July 31 and Aug. 4: 0.96 percent

4. Synergy Pharmaceuticals

Opened: $4.06 on July 31
Peaked at open
Closed: $3.72 on Aug. 4
Percent change between July 31 and Aug. 4: -8.37 percent

5. Valeant Pharmaceuticals

Opened: $16.87 on July 31
Peaked at open
Closed: $15.12 on Aug. 4
Percent change between July 31 and Aug. 4: -10.37 percent

More articles on gastroenterology:
Ironwood Pharmaceuticals reports Q2 revenues of $65.1M — 4 insights
GI center to know: Gastro Group & EndoCenter
GI leader to know: Dr. Anthony Albright of Gastro Group & EndoCenter

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.